Press Releases WntResearch AB

Equities

WNT

SE0022239901

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 02/06/2024 BST			5-day change	1st Jan Change
10.8 ^SEK	+4.25%		+61.19%	+17.39%

05-03	WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-29	WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

WntResearch : Presentationen från AGM.	05-27	PU
WntResearch's CEO to BioStock: "If the effect is confirmed, there are good opportunities for licensing agreements next year"	05-08	AQ
BioStock: WntResearch's new CEO comments on his first month in the position	04-02	AQ
Resigning WntResearch CEO tells BioStock: "It will be exciting to follow!"	03-01	AQ
WntResearch initiates collaboration with Business Sweden with the goal of establishing commercial partnerships for Foxy-5 in Japan and South Korea	02-26	AQ
WntResearch continues to the next step in the phase 2 study NeoFox with the highest evaluated dose of Foxy-5	02-12	AQ
WntResearch announces the last day for trading in BTU and the first day for trading in warrants series TO 7 and warrants series TO 8	02-08	AQ
WntResearch carries out a directed issue of units to underwriters in connection with the completed rights issue	02-07	AQ
WntResearch publishes outcome in rights issue	01-31	AQ
WntResearch's co-founder applies for subscription of additional units in the ongoing rights issue with a last day for subscription on 29 January 2024	01-24	AQ
WntResearch publishes prospectus in connection with rights issue	01-08	AQ
Bulletin from the extraordinary general meeting in Wntresearch AB on 22 December 2023	12-22	AQ
WntResearch continues to the second dose group in clinical proof of concept study of Foxy-5	12-06	AQ
WntResearch's CEO: "In a better position than ever"	11-21	AQ
BioStock: WntResearch recruits first patient in restart of NeoFox	20/10/23	AQ
BioStock: New patent strengthens WntResearch	06/10/23	AQ
BioStock Investor Meeting: WntResearch	27/09/23	AQ
BioStock: WntResearch hopes for in-depth talks about Foxy-5	23/08/23	AQ
BioStock: New study plan approved for WntResearch's phase II study	14/07/23	AQ
BioStock: WntResearch receives attention for results with Foxy-5 in AML	29/06/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases WntResearch AB

Equities

WNT

SE0022239901

Press Releases

Filters